Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Ptc Therapeutics (PTCT) EPS (Basic): 2011-2024

Historic EPS (Basic) for Ptc Therapeutics (PTCT) over the last 14 years, with Dec 2024 value amounting to -$4.73.

  • Ptc Therapeutics' EPS (Basic) rose 114.39% to $0.20 in Q3 2025 from the same period last year, while for Sep 2025 it was $9.61, marking a year-over-year increase of 261.78%. This contributed to the annual value of -$4.73 for FY2024, which is 43.49% up from last year.
  • As of FY2024, Ptc Therapeutics' EPS (Basic) stood at -$4.73, which was up 43.49% from -$8.37 recorded in FY2023.
  • Ptc Therapeutics' EPS (Basic)'s 5-year high stood at -$4.73 during FY2024, with a 5-year trough of -$8.37 in FY2023.
  • In the last 3 years, Ptc Therapeutics' EPS (Basic) had a median value of -$7.79 in 2022 and averaged -$6.96.
  • As far as peak fluctuations go, Ptc Therapeutics' EPS (Basic) slumped by 55.50% in 2020, and later surged by 43.49% in 2024.
  • Yearly analysis of 5 years shows Ptc Therapeutics' EPS (Basic) stood at -$6.64 in 2020, then dropped by 11.90% to -$7.43 in 2021, then fell by 4.85% to -$7.79 in 2022, then dropped by 7.45% to -$8.37 in 2023, then soared by 43.49% to -$4.73 in 2024.